Characterizing the RNA-mediated recruitment of histone deacetylases to chromatin
表征 RNA 介导的组蛋白脱乙酰酶向染色质的募集
基本信息
- 批准号:10680276
- 负责人:
- 金额:$ 5.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:Affinity ChromatographyAntisense RNABindingBinding ProteinsBinding SitesCancerousCell CycleCell NucleusCellsChromatinComplexDNA BindingDNA-Binding ProteinsDataEnzymesFutureGene ExpressionGene Expression RegulationGene SilencingGene TargetingGenesGeneticGenomeGuide RNAHDAC1 geneHDAC3 geneHealthHistone DeacetylaseHistone Deacetylase InhibitorHistone DeacetylationHumanImmunoprecipitationKnock-outLinkMalignant NeoplasmsMass Spectrum AnalysisMeasuresMediatingMethodsMissionMolecularMultiprotein ComplexesMutateNuclearPathologyPatientsPharmaceutical PreparationsProtein IsoformsProteinsRNARNA BindingRNA-Binding ProteinsRepressionResearchResearch Project GrantsRoleSiteSpecificitySuppressor-Effector T-LymphocytesTestingTherapeuticTimeToxic effectTumor Suppressor GenesUnited States National Institutes of HealthUntranslated RNAWorkX Chromosomecancer therapycancer typechromatin modificationcrosslinkeffective therapyexperimental studygene repressiongenetic manipulationgenetic regulatory proteingenomic locusimprovedin vivoinhibitorlink proteinmRNA Precursornovelpharmacologicprotein complexpublic databaserecruitside effecttherapeutic targettranscription factortumor
项目摘要
PROJECT SUMMARY
Global histone deacetylation is linked to many types of cancer and is controlled by histone deacetylases
(HDACs). Although HDAC inhibitors are widely used in cancer treatment, their activity does not target specific
HDAC isoforms nor specific genes and therefore results in significant side effects for patients. Thus, there is a
pressing need to target HDAC activity in a highly precise, gene-specific manner to develop safer and more
effective treatments. The overall objective of this proposal is to understand how HDACs are recruited to specific
genome regions. Because HDACs do not possess intrinsic DNA binding activity, they are thought to be recruited
to chromatin through interactions with DNA binding proteins, though this mechanism has not been fully explored.
Recently, our lab and others identified that the SHARP RNA-binding protein directly interacts with the Xist long
noncoding RNA (lncRNA) to specifically recruit HDAC3 to the future inactive X chromosome (Xi). In this way, the
Xist-SHARP/SMRT/HDAC3 repressive complex deacetylates histones and silences gene expression on the Xi.
Our lab has also demonstrated that SHARP localizes to many nuclear sites (beyond the Xi) in an RNA-dependent
manner, raising the question of which additional RNAs recruit it (along with HDAC3) and to what specific genomic
locations. Notably, nearly all human HDACs associate within multi-protein complexes containing SHARP and
other RNA-binding proteins, suggesting that this mechanism of RNA-guidance may extend beyond SHARP and
Xist.
I hypothesize that HDAC complexes are recruited by RNAs to achieve specificity to their various regulatory
targets throughout the nucleus. First, I will determine which SHARP-RNA interactions are functionally important
by genetically perturbing the SHARP binding sites of candidate RNAs. I will then measure effects on gene
expression and if HDAC3 activity is required for these effects (Aim 1). Second, I will comprehensively identify
RNA-binding proteins associated with other cancer-associated HDACs and define their in vivo RNA binding sites.
I will then determine which protein-bound candidate RNAs from this screen are regulated in an HDAC-dependent
manner (Aim 2). The proposed research has the potential to transform our understanding of RNAs and RNA-
binding proteins as central regulators in organizing chromatin modifications by HDACs in both normal and
cancerous cell states.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Kang Guo其他文献
James Kang Guo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于小鼠多组织和细胞链特异性RNA-seq数据的Antisense RNA分析及数据库构建
- 批准号:31271385
- 批准年份:2012
- 资助金额:95.0 万元
- 项目类别:面上项目
相似海外基金
Investigating the Role of Antisense RNA in the CCL3/CCR5/RALY Pathway
研究反义 RNA 在 CCL3/CCR5/RALY 通路中的作用
- 批准号:
2611968 - 财政年份:2021
- 资助金额:
$ 5.27万 - 项目类别:
Studentship
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
- 批准号:
10651684 - 财政年份:2020
- 资助金额:
$ 5.27万 - 项目类别:
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
- 批准号:
10450115 - 财政年份:2020
- 资助金额:
$ 5.27万 - 项目类别:
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
- 批准号:
10033207 - 财政年份:2020
- 资助金额:
$ 5.27万 - 项目类别:
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
- 批准号:
10256018 - 财政年份:2020
- 资助金额:
$ 5.27万 - 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
- 批准号:
10435493 - 财政年份:2019
- 资助金额:
$ 5.27万 - 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
- 批准号:
10652579 - 财政年份:2019
- 资助金额:
$ 5.27万 - 项目类别:
Alzheimer's Administrative Supplement - An antisense RNA-mediated regulatory program that drives cancer metastasis
阿尔茨海默氏症行政补充——一种驱动癌症转移的反义 RNA 介导的调控程序
- 批准号:
10117474 - 财政年份:2019
- 资助金额:
$ 5.27万 - 项目类别:
Isolation and characterization of novel peptides derived from antisense RNA
反义 RNA 衍生的新型肽的分离和表征
- 批准号:
19K06776 - 财政年份:2019
- 资助金额:
$ 5.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
- 批准号:
10177973 - 财政年份:2019
- 资助金额:
$ 5.27万 - 项目类别:














{{item.name}}会员




